These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7838530

  • 21. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H, Wierenga AT, Eggen BJ, Vellenga E.
    Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
    [Abstract] [Full Text] [Related]

  • 22. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 23. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA, Greenberg AH, Wright JA.
    J Cell Physiol; 1993 Aug 15; 156(2):272-9. PubMed ID: 8344985
    [Abstract] [Full Text] [Related]

  • 24. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment.
    Schmid G, Kramer MP, Wesierska-Gadek J.
    J Cell Physiol; 2009 May 15; 219(2):459-69. PubMed ID: 19170070
    [Abstract] [Full Text] [Related]

  • 29. TGF beta regulation of cell proliferation.
    Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF, Serra R.
    Princess Takamatsu Symp; 1994 May 15; 24():250-63. PubMed ID: 8983080
    [Abstract] [Full Text] [Related]

  • 30. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC, Levine AJ.
    Cell Growth Differ; 1994 Jan 15; 5(1):61-71. PubMed ID: 8123594
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene.
    Lu SL, Kawabata M, Imamura T, Miyazono K, Yuasa Y.
    Biochem Biophys Res Commun; 1999 Jun 07; 259(2):385-90. PubMed ID: 10362519
    [Abstract] [Full Text] [Related]

  • 33. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
    Wesierska-Gadek J, Schmid G.
    Cell Mol Biol Lett; 2001 Jun 07; 6(2):117-40. PubMed ID: 11544635
    [Abstract] [Full Text] [Related]

  • 34. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

  • 35. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF, Angioli R, Unal AD, Sevin BU, Madrigal M, Estape R, Averette HE.
    Gynecol Oncol; 1997 Jul 29; 66(1):94-102. PubMed ID: 9234928
    [Abstract] [Full Text] [Related]

  • 36. Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells.
    Sheng H, Shao J, Hooton EB, Tsujii M, DuBois RN, Beauchamp RD.
    Cell Growth Differ; 1997 Apr 29; 8(4):463-70. PubMed ID: 9101092
    [Abstract] [Full Text] [Related]

  • 37. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
    Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C.
    Cancer Res; 1994 Jan 15; 54(2):575-81. PubMed ID: 8275496
    [Abstract] [Full Text] [Related]

  • 38. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P, Russo J, Mgbonyebi OP, Russo IH.
    Anticancer Res; 1998 Jan 15; 18(6A):4003-10. PubMed ID: 9891438
    [Abstract] [Full Text] [Related]

  • 39. Correlated abnormalities of transforming growth factor-beta 1 response and p53 expression in thyroid epithelial cell transformation.
    Wyllie FS, Dawson T, Bond JA, Goretzki P, Game S, Prime S, Wynford-Thomas D.
    Mol Cell Endocrinol; 1991 Apr 15; 76(1-3):13-21. PubMed ID: 1820969
    [Abstract] [Full Text] [Related]

  • 40. Biochemical, immunological, and functional aspects of the growth-suppressor/oncoprotein p53.
    Montenarh M.
    Crit Rev Oncog; 1992 Apr 15; 3(3):233-56. PubMed ID: 1616956
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.